BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioCapital

  Acumen presents poster describing method to standardize amyloid beta oligomer assays supporting therapeutic development for early Alzheimer’s disease

  Scientists at Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) have developed a synthetic model to potentially standardize the study of soluble amyloid beta oligomers (AβOs), toxic proteins that accumulate early in Alzheimer’s disease (AD).

  August 1, 2022

   · 

  4 min read
• Changed Number of Shares and Votes in IRLAB Therapeutics AB

  IRLAB announced that the number of votes and shares in IRLAB Therapeutics AB have changed as a result of the share issue that was concluded in April 2022.

  August 1, 2022

   · 

  2 min read
• Deals

  XVIVO Enters into an Agreement to Acquire its Italian Distributor - Securing a Unique Business Model

  XVIVO Perfusion AB has signed an agreement to acquire 100 percent of the shares in Avionord S.r.l.'s machine and perfusion business for a purchase price amounting to a maximum of EUR 12.0 million.

  August 1, 2022

   · 

  6 min read
• Business

  ESPEROVAX AND LIFE MAGNETICS TO DELIVER NEW ORAL THERAPEUTIC TO COLORECTAL PATIENTS

  Esperovax, a leading developer of oral mRNA biologics, and Life Magnetics, Inc., creators of RNA stabilization technology, today announced the signing of an agreement to co-develop an innovative new oral RNA therapeutic delivery system for colorectal cancer patients that can be stored at room temperature.

  August 1, 2022

   · 

  1 min read